Natera (NASDAQ: NTRA)
Natera Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Natera Company Info
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
News & Analysis
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Investing in Genetic Testing Stocks
SPDR S&P Biotech ETF (XBI): How to Buy
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Which Company Owns Cash App?
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Valuation
Earnings Transcripts
Natera Inc (NTRA) Q3 2021 Earnings Call Transcript
NTRA earnings call for the period ending September 30, 2021.
Natera (NTRA) Q1 2020 Earnings Call Transcript
NTRA earnings call for the period ending March 31, 2020.
Natera (NTRA) Q4 2019 Earnings Call Transcript
NTRA earnings call for the period ending December 31, 2019.
Natera (NTRA) Q2 2019 Earnings Call Transcript
NTRA earnings call for the period ending June 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.